| Term 
 | Definition 
 
        | "false transmitter" that inhibits NE synthesis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks NE uptake (vesicle) and storage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks adrenergic reuptake |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits breakdown of sympathetic neurotransmitters |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks cholinergic reuptake |  | 
        |  | 
        
        | Term 
 
        | Donepezil Organophosphates
 |  | Definition 
 
        | Inhibits cholinergic breakdown |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks M1 (neural) receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks M2 (cardiac) receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks M3 (glands/smooth muscle) receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-specific muscarinic blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks nicotinic receptor at skeletal muscle (Nm) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks nicotinic receptor at neuron/ganglia (Nn) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks nicotinic receptors in CNS (brain and spinal cord) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS muscarinic antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylcholine Methacholine
 Carbachol
 Bethanechol
 |  | Definition 
 
        | Choline esters that are muscarinic agonists |  | 
        |  | 
        
        | Term 
 
        | Succinylcholine and decamethonium |  | Definition 
 
        | Depolarizing agents as neuromuscular junction blockers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Competitive agents as neuromuscular junction blockers |  | 
        |  | 
        
        | Term 
 
        | Arecoline Pilocarpine
 Muscarine
 |  | Definition 
 
        | Alkaloid muscarinic agonists |  | 
        |  |